[Clinical staging of prostate cancer]
- PMID: 9750488
[Clinical staging of prostate cancer]
Abstract
Clinical staging of prostate cancer was reviewed on the basis of TNM classification edited by UICC in 1997. In this revision, (1) T1c was newly categorized among T1 for cases of high PSA level without any abnormal sign of DRE, (2) T2 was subdivided into T2a and T2b in accordance with unilateral or bilateral nodule in the prostate, respectively, (3) T3 was also subdivided into T3a with capsular invasion and T3b with seminal vesicle invasion. It is hoped that present classification will become useful tools for the detection of the tumor burden cancer patients.
Similar articles
-
Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.J Urol. 2003 Jun;169(6):2129-35. doi: 10.1097/01.ju.0000065763.21602.14. J Urol. 2003. PMID: 12771734
-
Clinical and pathological characteristics, and recurrence rates of stage T1c versus T2a or T2b prostate cancer.J Urol. 1999 May;161(5):1525-9. J Urol. 1999. PMID: 10210388
-
The prognostic role of the pathological T2 subclassification for prostate cancer in the 2002 Tumour-Nodes-Metastasis staging system.BJU Int. 2008 Aug;102(4):438-41. doi: 10.1111/j.1464-410X.2008.07611.x. Epub 2008 Mar 11. BJU Int. 2008. PMID: 18336608
-
T1c cancer: what is it?Semin Urol Oncol. 1995 Aug;13(3):173-5. Semin Urol Oncol. 1995. PMID: 8521128 Review.
-
[Clinical and pathological staging of prostate cancer].Nihon Rinsho. 2005 Feb;63(2):225-30. Nihon Rinsho. 2005. PMID: 15714970 Review. Japanese.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous